These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7114924)

  • 1. Natural killer cell activity in untreated systemic lupus erythematosus.
    Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
    Ann Rheum Dis; 1982 Aug; 41(4):417-20. PubMed ID: 7114924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer augmentation in systemic lupus erythematosus via a soluble mediator derived from human lymphocytes.
    Kaufman DB
    Arthritis Rheum; 1982 May; 25(5):562-7. PubMed ID: 7082401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Sumiya M; Gonda N; Kano S; Takaku F
    Lancet; 1979 Nov; 2(8150):1023. PubMed ID: 91760
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus.
    Oshimi K; Gonda N; Sumiya M; Kano S
    Clin Exp Immunol; 1980 Apr; 40(1):83-8. PubMed ID: 7389219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro augmentation of human natural killer cell activity by pokeweed mitogen-stimulated lymphocytes].
    Matsumoto Y; Katoh Y
    Rinsho Byori; 1983 Oct; 31(10):1122-6. PubMed ID: 6674584
    [No Abstract]   [Full Text] [Related]  

  • 7. Natural and antibody-dependent cellular cytotoxicity in children with systemic lupus erythematosus and juvenile dermatomyositis.
    Miller ML; Lantner R; Pachman LM
    J Rheumatol; 1983 Aug; 10(4):640-2. PubMed ID: 6620266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
    Ewan PW; Barrett HM; Pusey CD
    J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
    Zhao XZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Láng I; Gergely P
    Immunol Commun; 1982; 11(6):431-40. PubMed ID: 7169224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of ultraviolet irradiation on natural killer cell function in systemic lupus erythematosus.
    Nived O; Johansson I; Sturfelt G
    Ann Rheum Dis; 1992 Jun; 51(6):726-30. PubMed ID: 1616354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus.
    Spada R; Rojas JM; Barber DF
    J Leukoc Biol; 2015 Oct; 98(4):479-87. PubMed ID: 26216938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Arthritis Rheum; 1983 Dec; 26(12):1452-9. PubMed ID: 6651894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients.
    Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity to interferon of NK cells from patients with systemic lupus erythematosus.
    Fitzharris P; Alcocer J; Stephens HA; Knight RA; Snaith ML
    Clin Exp Immunol; 1982 Jan; 47(1):110-8. PubMed ID: 6178542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferons and systemic lupus erythematosus.
    Bankhurst AD
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():63-7. PubMed ID: 2441046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circulating immune complexes and NK activity in systemic lupus erythematosus].
    Haas H; Havel A; Lange A; Gross W; Flad HD; Schlaak M
    Immun Infekt; 1984 Apr; 12(2):109-10. PubMed ID: 6534842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.